Selected article for: "International license and SEIR model"

Author: Qingyang Xu; Shomesh Chaudhuri; Danying Xiao; Andrew W Lo
Title: Bayesian Adaptive Clinical Trials for Anti-Infective Therapeutics during Epidemic Outbreaks
  • Document date: 2020_4_14
  • ID: 20hk99h4_25
    Snippet: By design, this loss function penalizes Type I errors early in the epidemic by the susceptible term, . We subtract the base level from since the multi-group SEIR model predicts that subjects will not be infected by the epidemic. A Type I error . CC-BY 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity......
    Document: By design, this loss function penalizes Type I errors early in the epidemic by the susceptible term, . We subtract the base level from since the multi-group SEIR model predicts that subjects will not be infected by the epidemic. A Type I error . CC-BY 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

    Search related documents:
    Co phrase search for related documents
    • international license and SEIR model: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • international license and Type error: 1, 2, 3
    • loss function and SEIR model: 1, 2, 3, 4
    • loss function and Type error: 1, 2
    • multi group SEIR model and SEIR model: 1, 2, 3, 4, 5, 6
    • SEIR model and susceptible term: 1, 2, 3, 4